跳至主要内容
临床试验/NL-OMON41581
NL-OMON41581已完成不适用

Prospective comparative study between Deflux® and Vantris® for endoscopic treatment of vesico-ureteral reflux in children. - DeVan studie

Vrije Universiteit Medisch Centrum0 个研究点目标入组 330 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • VUR grade II to V, established through MCUG < 1 year before surgery
  • No or treated dysfunctional voiding pattern
  • No or treated constipation
  • No active urinary-tract infection on the day of surgery
  • Child between 1 and 18 years of age
  • Normal serum creatinin level

排除标准

  • Recurrent residual after micturition of more than 10% of the functional bladder capacity
  • Neurogenic or non-neurogenic bladder disorder or a history of intermittent catheterization
  • Earlier surgery to the bladder or the ureter
  • urinary-tract infection, not treated
  • Obstipation, not treated
  • Children of parents who, for principal or other reasons, refuse to administer antibiotic prophylaxis when the paediatric urologist or treating physician indicates this to be necessary.
  • Non-compliance, proven during the progress of the case history so far
  • Abnormal level of serum creatinin

研究者

相似试验